Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Altered effect of dopamine transporter 3'UTR VNTR genotype on prefrontal and striatal function in schizophrenia.

Prata DP, Mechelli A, Picchioni MM, Fu CH, Toulopoulou T, Bramon E, Walshe M, Murray RM, Collier DA, McGuire P.

Arch Gen Psychiatry. 2009 Nov;66(11):1162-72. doi: 10.1001/archgenpsychiatry.2009.147.

PMID:
19884604
2.

Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder.

Brown AB, Biederman J, Valera EM, Doyle AE, Bush G, Spencer T, Monuteaux MC, Mick E, Whitfield-Gabrieli S, Makris N, LaViolette PS, Oscar-Berman M, Faraone SV, Seidman LJ.

Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):365-75. doi: 10.1002/ajmg.b.31022.

3.

Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuroimaging?

Plomp E, Van Engeland H, Durston S.

Neuroscience. 2009 Nov 24;164(1):230-40. doi: 10.1016/j.neuroscience.2009.07.024. Epub 2009 Jul 18. Review.

PMID:
19619618
4.

Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention.

Tomasi D, Volkow ND, Wang R, Telang F, Wang GJ, Chang L, Ernst T, Fowler JS.

PLoS One. 2009 Jun 30;4(6):e6102. doi: 10.1371/journal.pone.0006102.

5.

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.

Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH Jr, Stein MA.

J Child Adolesc Psychopharmacol. 2009 Jun;19(3):233-9. doi: 10.1089/cap.2008.0133.

6.

Candidate gene studies of ADHD: a meta-analytic review.

Gizer IR, Ficks C, Waldman ID.

Hum Genet. 2009 Jul;126(1):51-90. doi: 10.1007/s00439-009-0694-x. Epub 2009 Jun 9. Review.

PMID:
19506906
7.

ADHD and DAT1: further evidence of paternal over-transmission of risk alleles and haplotype.

Hawi Z, Kent L, Hill M, Anney RJ, Brookes KJ, Barry E, Franke B, Banaschewski T, Buitelaar J, Ebstein R, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen HC, Faraone SV, Asherson P, Gill M.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):97-102. doi: 10.1002/ajmg.b.30960.

PMID:
19388000
8.

Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Zhu J, Reith ME.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):393-409. Review.

9.

Dissociable neural effects of stimulus valence and preceding context during the inhibition of responses to emotional faces.

Schulz KP, Clerkin SM, Halperin JM, Newcorn JH, Tang CY, Fan J.

Hum Brain Mapp. 2009 Sep;30(9):2821-33. doi: 10.1002/hbm.20706.

10.

Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.

Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A.

Cell Signal. 2009 Jan;21(1):87-94. doi: 10.1016/j.cellsig.2008.09.011. Epub 2008 Sep 30.

11.

Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD.

Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, Naber M, Scheffer H, Kiemeney LA, Kan CC, Kooij JJ, Buitelaar JK.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1576-9. doi: 10.1002/ajmg.b.30861.

PMID:
18802924
12.

Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.

Durston S, Fossella JA, Mulder MJ, Casey BJ, Ziermans TB, Vessaz MN, Van Engeland H.

J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):61-7. doi: 10.1097/chi.0b013e31815a5f17.

PMID:
18174826
13.

Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs.

Johansson S, Halleland H, Halm√ły A, Jacobsen KK, Landaas ET, Dramsdahl M, Fasmer OB, Bergsholm P, Lundervold AJ, Gillberg C, Hugdahl K, Knappskog PM, Haavik J.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1470-5.

PMID:
18081165
14.

Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition.

Aron AR, Durston S, Eagle DM, Logan GD, Stinear CM, Stuphorn V.

J Neurosci. 2007 Oct 31;27(44):11860-4. Review. No abstract available.

15.

Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.

Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.

Arch Gen Psychiatry. 2007 Aug;64(8):932-40.

PMID:
17679638
16.

Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue.

Brookes KJ, Neale BM, Sugden K, Khan N, Asherson P, D'Souza UM.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1070-8.

PMID:
17579365
17.

Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice.

Wu N, Cepeda C, Zhuang X, Levine MS.

J Neurophysiol. 2007 Jul;98(1):423-32. Epub 2007 May 23.

18.
19.

Activation of right inferior frontal gyrus during response inhibition across response modalities.

Chikazoe J, Konishi S, Asari T, Jimura K, Miyashita Y.

J Cogn Neurosci. 2007 Jan;19(1):69-80.

PMID:
17214564
20.

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

Joober R, Grizenko N, Sengupta S, Amor LB, Schmitz N, Schwartz G, Karama S, Lageix P, Fathalli F, Torkaman-Zehi A, Ter Stepanian M.

Neuropsychopharmacology. 2007 Jun;32(6):1370-6. Epub 2006 Oct 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk